233 related articles for article (PubMed ID: 19661132)
41. Role of ferritin alterations in human breast cancer cells.
Shpyleva SI; Tryndyak VP; Kovalchuk O; Starlard-Davenport A; Chekhun VF; Beland FA; Pogribny IP
Breast Cancer Res Treat; 2011 Feb; 126(1):63-71. PubMed ID: 20390345
[TBL] [Abstract][Full Text] [Related]
42. PAC, a novel curcumin analogue, has anti-breast cancer properties with higher efficiency on ER-negative cells.
Al-Hujaily EM; Mohamed AG; Al-Sharif I; Youssef KM; Manogaran PS; Al-Otaibi B; Al-Haza'a A; Al-Jammaz I; Al-Hussein K; Aboussekhra A
Breast Cancer Res Treat; 2011 Jul; 128(1):97-107. PubMed ID: 20680677
[TBL] [Abstract][Full Text] [Related]
43. A comparison of two orally bioavailable anti-cancer agents, IRC-110160 and STX140.
Foster PA; Stengel C; Ali T; Leese MP; Potter BV; Reed MJ; Purohit A; Newman SP
Anticancer Res; 2008; 28(3A):1483-91. PubMed ID: 18630502
[TBL] [Abstract][Full Text] [Related]
44. The selective cytotoxic activity in breast cancer cells by an anthranilic alcohol-derived acyclic 5-fluorouracil O,N-acetal is mediated by endoplasmic reticulum stress-induced apoptosis.
Caba O; Rodríguez-Serrano F; Díaz-Gavilán M; Conejo-García A; Ortiz R; Martínez-Amat A; Alvarez P; Gallo MA; Campos JM; Marchal JA; Aránega A
Eur J Med Chem; 2012 Apr; 50():376-82. PubMed ID: 22373735
[TBL] [Abstract][Full Text] [Related]
45. A novel taspine derivative, HMQ1611, inhibits breast cancer cell growth via estrogen receptor α and EGF receptor signaling pathways.
Zhan Y; Zhang Y; Liu C; Zhang J; Smith WW; Wang N; Chen Y; Zheng L; He L
Cancer Prev Res (Phila); 2012 Jun; 5(6):864-73. PubMed ID: 22496388
[TBL] [Abstract][Full Text] [Related]
46. Calycosin promotes proliferation of estrogen receptor-positive cells via estrogen receptors and ERK1/2 activation in vitro and in vivo.
Chen J; Liu L; Hou R; Shao Z; Wu Y; Chen X; Zhou L
Cancer Lett; 2011 Sep; 308(2):144-51. PubMed ID: 21612861
[TBL] [Abstract][Full Text] [Related]
47. Adeno-associated virus-mediated survivin mutant Thr34Ala cooperates with oxaliplatin to inhibit tumor growth and angiogenesis in colon cancer.
Xue Z; Sun PH; Zhu LM; Jiang SH; Qiao MM; Chi AL; Tu SP
Oncol Rep; 2011 Apr; 25(4):1039-46. PubMed ID: 21279308
[TBL] [Abstract][Full Text] [Related]
48. An oestrogen-dependent model of breast cancer created by transformation of normal human mammary epithelial cells.
Duss S; André S; Nicoulaz AL; Fiche M; Bonnefoi H; Brisken C; Iggo RD
Breast Cancer Res; 2007; 9(3):R38. PubMed ID: 17573968
[TBL] [Abstract][Full Text] [Related]
49. Cytotoxic efficacy of a novel dinuclear platinum(II) complex in human breast cancer cells.
Bielawska A; Popławska B; Surazyński A; Czarnomysy R; Bielawski K
Eur J Pharmacol; 2010 Sep; 643(1):34-41. PubMed ID: 20598681
[TBL] [Abstract][Full Text] [Related]
50. Coadministration of nanosystems of short silencing RNAs targeting oestrogen receptor alpha and anti-oestrogen synergistically induces tumour growth inhibition in human breast cancer xenografts.
Bouclier C; Marsaud V; Bawa O; Nicolas V; Moine L; Opolon P; Renoir JM
Breast Cancer Res Treat; 2010 Jul; 122(1):145-58. PubMed ID: 19771505
[TBL] [Abstract][Full Text] [Related]
51. Cancer-selective targeting and cytotoxicity by liposomal-coupled lysosomal saposin C protein.
Qi X; Chu Z; Mahller YY; Stringer KF; Witte DP; Cripe TP
Clin Cancer Res; 2009 Sep; 15(18):5840-51. PubMed ID: 19737950
[TBL] [Abstract][Full Text] [Related]
52. Activity of the antiestrogenic cajanin stilbene acid towards breast cancer.
Fu Y; Kadioglu O; Wiench B; Wei Z; Wang W; Luo M; Yang X; Gu C; Zu Y; Efferth T
J Nutr Biochem; 2015 Nov; 26(11):1273-82. PubMed ID: 26365581
[TBL] [Abstract][Full Text] [Related]
53. The cyclin-dependent kinase inhibitor SNS-032 induces apoptosis in breast cancer cells via depletion of Mcl-1 and X-linked inhibitor of apoptosis protein and displays antitumor activity in vivo.
Xie G; Tang H; Wu S; Chen J; Liu J; Liao C
Int J Oncol; 2014 Aug; 45(2):804-12. PubMed ID: 24865236
[TBL] [Abstract][Full Text] [Related]
54. Xenoestrogens and the induction of proliferative effects in breast cancer cells via direct activation of oestrogen receptor alpha.
Recchia AG; Vivacqua A; Gabriele S; Carpino A; Fasanella G; Rago V; Bonofiglio D; Maggiolini M
Food Addit Contam; 2004 Feb; 21(2):134-44. PubMed ID: 14754635
[TBL] [Abstract][Full Text] [Related]
55. Human chorionic gonadotropin suppresses human breast cancer cell growth directly via p53-mediated mitochondrial apoptotic pathway and indirectly via ovarian steroid secretion.
Yuri T; Kinoshita Y; Emoto Y; Yoshizawa K; Tsubura A
Anticancer Res; 2014 Mar; 34(3):1347-54. PubMed ID: 24596382
[TBL] [Abstract][Full Text] [Related]
56. Cytotoxic activity of nemorosone in human MCF-7 breast cancer cells.
Popolo A; Piccinelli AL; Morello S; Sorrentino R; Osmany CR; Rastrelli L; Pinto A
Can J Physiol Pharmacol; 2011 Jan; 89(1):50-7. PubMed ID: 21186377
[TBL] [Abstract][Full Text] [Related]
57. Curcumin polymers as anticancer conjugates.
Tang H; Murphy CJ; Zhang B; Shen Y; Van Kirk EA; Murdoch WJ; Radosz M
Biomaterials; 2010 Sep; 31(27):7139-49. PubMed ID: 20591475
[TBL] [Abstract][Full Text] [Related]
58. Anticancer effects of wogonin in both estrogen receptor-positive and -negative human breast cancer cell lines in vitro and in nude mice xenografts.
Chung H; Jung YM; Shin DH; Lee JY; Oh MY; Kim HJ; Jang KS; Jeon SJ; Son KH; Kong G
Int J Cancer; 2008 Feb; 122(4):816-22. PubMed ID: 17957784
[TBL] [Abstract][Full Text] [Related]
59. Chemotherapy with hybrid liposomes for human breast tumors along with apoptosis in vivo.
Shimoda S; Ichihara H; Matsumoto Y; Ueoka R
Int J Pharm; 2009 May; 372(1-2):162-8. PubMed ID: 19429276
[TBL] [Abstract][Full Text] [Related]
60. 17beta-estradiol attenuates programmed cell death in cortical pericontusional zone following traumatic brain injury via upregulation of ERalpha and inhibition of caspase-3 activation.
Li LZ; Bao YJ; Zhao M
Neurochem Int; 2011 Jan; 58(1):126-33. PubMed ID: 21093516
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
